Filter

Showing 1–12 of 154 results

2020 FDA Approvals Adalimumab
+
 Quick View

anti-human

Adalimumab Biosimilar – Research Grade [ICH4001]

$704.00 – $4,080.00
2020 FDA Approvals Ado-trastuzumab-emtansine
+
 Quick View

anti-human

Ado-trastuzumab emtansine Biosimilar – Research Grade [ICH4014]

$1,122.00 – $2,550.00
2020 FDA Approvals Aflibercept
+
 Quick View

anti-human

Aflibercept Biosimilar – Research Grade [ICH4015]

$1,122.00 – $2,550.00
2020 FDA Approvals for Alemtuzumab
+
 Quick View

anti-human

Alemtuzumab Biosimilar – Research Grade [ICH4002]

$704.00 – $4,080.00
2020 FDA Approvals Alirocumab
+
 Quick View

anti-human

Alirocumab Biosimilar – Research Grade [ICH4016]

$704.00 – $4,080.00
+
 Quick View

anti-mouse

Anti-CD115 In Vivo Antibody – Low Endotoxin (AFS98) [ICH1068]

$320.00 – $2,378.00
+
 Quick View

anti-mouse

Anti-CD11C In Vivo Antibody – Low Endotoxin (N418) [ICH1050]

$320.00 – $2,140.00
Placeholder
+
 Quick View

anti-human

Anti-CD151 In Vivo Antibody – Low Endotoxin (50-6) [ICH1019]

$320.00 – $2,140.00
Placeholder
+
 Quick View

anti-mouse

Anti-CD19 In Vivo Antibody – Low Endotoxin (1D3) [ICH1052]

$320.00 – $2,378.00
Placeholder
+
 Quick View

anti-human

Anti-CD20 In Vivo Antibody – Low Endotoxin (2H7) [ICH1012]

$320.00 – $2,378.00
+
 Quick View

anti-mouse

Anti-CD278 In Vivo Antibody – Low Endotoxin (7E.17G9) [ICH1082]

$320.00 – $2,378.00
Placeholder
+
 Quick View

anti-mouse

Anti-CD3e In Vivo Antibody – Low Endotoxin (145-2C11) [ICH1041]

$320.00 – $2,378.00